BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24640610)

  • 1. A comparative legal analysis of social media advertising of drugs in Germany and the United States.
    Buechner B
    Food Drug Law J; 2013; 68(3):259-79, i-ii. PubMed ID: 24640610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal considerations for social media marketing by pharmaceutical industry.
    Yang YT; Chen B
    Food Drug Law J; 2014; 69(1):39-51, ii. PubMed ID: 24772685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal features of the drug advertising.
    Pashkov VM; Olefir AA; Bytyak OY
    Wiad Lek; 2017; 70(1):133-138. PubMed ID: 28343208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J; DeAndrea DC
    J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictions on the conduct of advertising of medicinal products in Poland and their violations.
    Czerw A; Marek EM
    Acta Pol Pharm; 2013; 70(4):769-76. PubMed ID: 23923402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
    Allen MC
    Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
    [No Abstract]   [Full Text] [Related]  

  • 8. Legislative and non-legislative regulations concerning Rx drug advertisement in the European Union and the United States--comparative analysis.
    Czerw A; Religioni U
    Acta Pol Pharm; 2012; 69(4):779-87. PubMed ID: 22876622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The advertising rights of medical representatives. 2: Presentation of the legal advertising framework according to the drug advertising law].
    Hüttl P; Heberer J; von Knoch M; Siegert M
    Chirurg; 2007 Dec; Suppl():421-5. PubMed ID: 18546571
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulating pharmaceutical advertising: what will work?
    Shapiro MF
    CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The federal regulation of prescription drug advertising and promotion.
    Kessler DA; Pines WL
    JAMA; 1990 Nov; 264(18):2409-15. PubMed ID: 2231998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug advertising--users want information. Report of telephone survey conducted by North-Rhine Westphalia Public Health Service on the topic of drug advertising and drug information for users].
    Puteanus U
    Gesundheitswesen; 2000 Oct; 62(10):516-24. PubMed ID: 11103563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health literacy knowledge among direct-to-consumer pharmaceutical advertising professionals.
    Mackert M
    Health Commun; 2011 Sep; 26(6):525-33. PubMed ID: 21469006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of prescription drug promotion: direct-to-consumer advertising.
    Baylor-Henry M; Drezin NA
    Clin Ther; 1998; 20 Suppl C():C86-95. PubMed ID: 9915094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of prescription drugs to consumers.
    Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
    N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 17. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efforts to ban direct-to-consumer advertising in New Zealand: a call to action.
    Hoffman JR; Cooper RJ
    Br J Gen Pract; 2003 Apr; 53(489):267-9. PubMed ID: 12879824
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct-to-consumer advertising of prescription drugs: European Commission persists in putting industry's interests first.
    Prescrire Int; 2013 Jan; 22(134):24-5, 27. PubMed ID: 23373084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns].
    Cianciara D
    Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.